The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic (Q41696444)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on December 1997

Language	Label	Description	Also known as
English	The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic	scientific article published on December 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

1 reference

Europe PubMed Central

The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

F Wolfe

1

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

language of work or name

0 references

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

6A

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

12S-18S

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Which traditional measures should be used in rheumatoid arthritis clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Reduced joint counts in controlled clinical trials in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Reduced joint counts in rheumatoid arthritis clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Reduced joint count indices in the evaluation of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Comparison of the validity and reliability of self-reported articular indices

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

The rapid assessment of disease activity in rheumatology (radar) questionnaire. Validity and sensitivity to change of a patient self-report measure of joint count and clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

The assessment of disease activity in rheumatoid arthritis using a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

The mortality of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Work disability in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Predictors of work disability in rheumatoid arthritis patients. A five-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Work disability among women with rheumatoid arthritis. The relative importance of disease, social, work, and family factors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Prognosis of functional capacity and work capacity in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Work disability in rheumatoid arthritis: effects of disease, social, and work factors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

A multicenter study of annual health service utilization and costs in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(97)90003-6

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41696444&oldid=1926032739"